These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28805182)

  • 1. Human induced pluripotent stem cells as a research tool in Alzheimer's disease.
    Robbins JP; Price J
    Psychol Med; 2017 Nov; 47(15):2587-2592. PubMed ID: 28805182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
    Marei HE; Khan MUA; Hasan A
    Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modeling neurological and psychiatric disorders in vitro using induced pluripotent stem cells: highlighting findings in Alzheimer's disease and schizophrenia].
    Hathy E; Kalman S; Apati A; Nemoda Z; Rethelyi JM
    Neuropsychopharmacol Hung; 2016 Dec; 18(4):188-198. PubMed ID: 28259862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer's Disease.
    Atkinson-Dell R; Mohamet L
    Adv Exp Med Biol; 2019; 1175():383-405. PubMed ID: 31583596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the Application of Induced Pluripotent Stem Cells in Alzheimer's Disease and Parkinson's Disease.
    Xu Y; Wang S; Zhu P
    Curr Stem Cell Res Ther; 2023; 18(2):154-162. PubMed ID: 35473516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
    Yang J; Li S; He XB; Cheng C; Le W
    Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
    Wu YY; Chiu FL; Yeh CS; Kuo HC
    Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important advances in Alzheimer's disease from the use of induced pluripotent stem cells.
    Majolo F; Marinowic DR; Machado DC; Da Costa JC
    J Biomed Sci; 2019 Feb; 26(1):15. PubMed ID: 30728025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Alzheimer's disease with iPSC-derived brain cells.
    Penney J; Ralvenius WT; Tsai LH
    Mol Psychiatry; 2020 Jan; 25(1):148-167. PubMed ID: 31391546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
    Tcw J
    Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
    Young JE; Goldstein LSB
    Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease modeling: ups, downs, and perspectives for human induced pluripotent stem cells.
    Wojda U; Kuznicki J
    J Alzheimers Dis; 2013; 34(3):563-88. PubMed ID: 23313930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's Disease.
    Cha MY; Kwon YW; Ahn HS; Jeong H; Lee YY; Moon M; Baik SH; Kim DK; Song H; Yi EC; Hwang D; Kim HS; Mook-Jung I
    Stem Cells Transl Med; 2017 Jan; 6(1):293-305. PubMed ID: 28170178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation.
    Chang KH; Lee-Chen GJ; Huang CC; Lin JL; Chen YJ; Wei PC; Lo YS; Yao CF; Kuo MW; Chen CM
    Mol Neurobiol; 2019 Jun; 56(6):3972-3983. PubMed ID: 30238389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry analysis of tau and amyloid-beta in iPSC-derived models of Alzheimer's disease and dementia.
    Arber C; Alatza A; Leckey CA; Paterson RW; Zetterberg H; Wray S
    J Neurochem; 2021 Oct; 159(2):305-317. PubMed ID: 33539581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease.
    Csöbönyeiová M; Polák Š; Danišovič L
    Rev Neurosci; 2016 Jul; 27(5):457-64. PubMed ID: 26812864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerating stem cell trials for Alzheimer's disease.
    Hunsberger JG; Rao M; Kurtzberg J; Bulte JWM; Atala A; LaFerla FM; Greely HT; Sawa A; Gandy S; Schneider LS; Doraiswamy PM
    Lancet Neurol; 2016 Feb; 15(2):219-230. PubMed ID: 26704439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of stem cell therapies of Alzheimer's disease.
    Wang ZB; Wang ZT; Sun Y; Tan L; Yu JT
    Ageing Res Rev; 2022 Sep; 80():101655. PubMed ID: 35660003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.